Expertise in
16
conditions

Jean-christophe C. Corvol

NS Park French Network, 
Paris, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
16
conditions
NS Park French Network, 
Paris, FR 

Overview

Jean-christophe Corvol practices practicing medicine in Paris, France.

Mr. Corvol is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Deep Brain Stimulation, and Gastrostomy.

He is actively involved in clinical research, co-authoring 240 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

NS Park French Network, Paris, France
Other Locations
Villejuif, France
Equipe 01-Neuropsychologie Interventionnelle L'Institut Mondor De Recherches Biomédicales, Université Paris Est Créteil, UMR 1239, CIC 1413, CIC 1402, CNRS UMR 7104, CIC 1414, CHU De Caen, Caen, France
Ivry-sur-seine, France
Strasbourg, France
CREST, Campus De Ker Lann, 51 Rue Blaise Pascal BP 37203 35172 Bruz Cedex, Rouez, 35172, France
CREST, ENSAI, Campus de Ker Lann
Bruz, France
Toulouse, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

The Parkinson's Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort
The Parkinson's Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort
Enrollment Status: Recruiting
Publish Date: July 27, 2026
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Evaluate the Long-term (3 Months) Efficacy of L-threo DOPS (DroxiDopa) on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With Multiple System Atrophy (MSA). Comparative Study Versus Placebo
Enrollment Status: Completed
Publish Date: April 08, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study)
Enrollment Status: Completed
Publish Date: April 06, 2026
Intervention Type: Drug
Study Phase: Phase 2
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Study of Pimavanserin Efficacy for the Treatment of Impulse Control Disorders in Parkinson's Disease
Enrollment Status: Completed
Publish Date: March 16, 2026
Intervention Type: Drug, Procedure, Behavioral
Study Drug: Pimavanserin
Study Phase: Phase 2
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease. European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone
Enrollment Status: Completed
Publish Date: February 05, 2026
Intervention Type: Drug
Study Drug: Deferiprone
Study Phase: Phase 2
Clinical, Molecular and by Neuroimaging Characterization of Monogenic Forms of Parkinsonism Syndromes: Mutations of the LRRK2 Gene.
Clinical, Molecular and by Neuroimaging Characterization of Monogenic Forms of Parkinsonism Syndromes: Mutations of the LRRK2 Gene.
Enrollment Status: Completed
Publish Date: January 23, 2025
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
Longitudinal Exploratory Prospective Evaluation of Clinical Evolution in Patients With Motor Predominant Parkinson Disease.
Longitudinal Exploratory Prospective Evaluation of Clinical Evolution in Patients With Motor Predominant Parkinson Disease.
Enrollment Status: Terminated
Publish Date: December 21, 2022
Double-Blind Randomized Placebo-Controlled Cross-Over Phase IIa Trial to Evaluate Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson's Disease Patients Using a Levodopa Challenge Test
Double-Blind Randomized Placebo-Controlled Cross-Over Phase IIa Trial to Evaluate Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson's Disease Patients Using a Levodopa Challenge Test
Enrollment Status: Completed
Publish Date: July 24, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

237 Total Publications

Radiological signature of levodopa responsiveness in Parkinson's disease: A data driven approach in a deep brain stimulation cohort.
Radiological signature of levodopa responsiveness in Parkinson's disease: A data driven approach in a deep brain stimulation cohort.
Journal: Neurobiology of disease
Published: June 22, 2026

Frequently Asked Questions about Jean-christophe C. Corvol

Is Jean-christophe C. Corvol a top-rated expert for Parkinson's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jean-christophe C. Corvol is classified as an Elite expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jean-christophe C. Corvol participate in research or clinical trials?

Yes. Jean-christophe C. Corvol has published 237 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Jean-christophe C. Corvol's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Corvol's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile